Skip to main content
SpringerLink
Log in

The New Insulins

Their Characteristics and Clinical Indications

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

In the past 10 years the techniques of gel filtration and ion exchange chromatography have made available insulins of markedly enhanced purity. These highly purified insulins have made immunological insulin resistance a rarity, and result in absent or clinically insignificant levels of insulin antibodies in insulin-treated diabetics. Insulin allergy has not been reported with highly purified insulins alone, and is rare even when the patient has previously received recrystallised insulin. Generalised allergic reactions to insulin and insulin resistance are associated with the enhanced immunological reaction to intermittent insulin therapy. The use of highly purified insulins for short courses of treatment is therefore mandatory, particularly in patients with infections. Injection-site lipoatrophy, a relatively common occurrence with the older insulins, disappears on changing to highly purified preparations.

Following a change to highly purified insulins, insulin dose requirements will fall gradually with insulin antibody levels. When switching from conventional beef to highly purified pork insulins, a more immediate change in dose requirements may occur so that prospective reductions in insulin dose are indicated.

It is still uncertain whether moderate levels of insulin antibodies are associated with any difference in metabolic control. This is partly a reflection of difficulties in measuring diabetic control, and partly a lack of properly designed studies. Current insulins of both older and newer Types give plasma insulin profiles that are far from physiological Insulin antibodies cross the placenta and may contribute to increased fetal insulin secretion and neonatal hypoglycaemia. Pre-pregnant patients should be changed to the newer preparations. Highly purified insulins cost little more than conventional insulins in the free market, and should be used in all newly diagnosed insulin-requiring diabetics.

More recently, human insulin has become available through both DNA recombinant technology and amino acid substitution techniques. It has proved to have identical characteristics to pork insulin both in vitro and in normal subjects. Clinical trials with human insulin are at present in progress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ahmed, M.; Gannon, M.C. and Nuttall, F.Q.: Postprandial plasma glucose, insulin, glucagon and triglyceride responses to a standard diet in normal subjects. Diabetologia 12: 61–67 (1976).

    PubMed  CAS  Google Scholar 

  • Alberti, K.G.M.M. and Nattrass, M.: Highly purified insulins. Diabetologia 15: 77–80 (1978).

    PubMed  CAS  Google Scholar 

  • Andersen, O.O. and Egeberg, J.: The clinical significance of insulin antibodies. Acta Paediatrica Scandinavica 270 (Suppl.): 63–68 (1977).

    PubMed  Google Scholar 

  • Andreani, D.; Javicoli, M.; Tamburrano, G. and Menzinger, G.: Comparative trials with monocomponent (MC) and mono-species (MS) pork insulin in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirements and on some complications. Hormone and Metabolic Research 6: 447–454 (1974).

    PubMed  CAS  Google Scholar 

  • Asplin, C.M.; Hartog, M. and Goldie, D.J.: Change of insulin dosage, circulating free and bound insulin and insulin antibodies on transferring diabetics from conventional to highly purified porcine insulin. Diabetologia 14: 99–105 (1978).

    PubMed  CAS  Google Scholar 

  • Berson, S.A. and Yalow, R.S.: Quantitative aspects of the reaction between insulin and insulin-binding antibody. Journal of Clinical Investigation 38: 1996–2016 (1959).

    PubMed  CAS  Google Scholar 

  • Berson, S.A. and Yalow, R.S.: Insulin in blood and insulin antibodies. American Journal of Medicine 40: 676–690 (1966).

    PubMed  CAS  Google Scholar 

  • Berson, S.A.; Yalow, R.S.; Bauman, A.; Rothschild, M.A. and Newerly, Y.: Insulin I131 metabolism in human subjects. Demonstration of insulin binding globulin in circulation of insulin treated subjects. Journal of Clinical Investigation 35: 170–190 (1956).

    PubMed  CAS  Google Scholar 

  • Binder, C.: Absorption of injected insulin. Acta Pharmacologia Toxicologia 27(Suppl. 2): 1–87 (1969).

    Google Scholar 

  • Bloom, S.R.; Barnes, A.J.; Adrian, T.E. and Polak, J.M.: Autoimmunity in diabetics induced by hormonal contaminants of insulin. Lancet 1: 14–17 (1979).

    PubMed  CAS  Google Scholar 

  • Bloom, S.R.; West, A.M.; Polak, J.M.; Barnes, A.J. and Adrian, T.E.: Hormonal contaminants of insulin; in Bloom (Ed.) Gut Hormones, pp.318–322 (Churchill Livingstone, Edinburgh, London, New York 1978).

    Google Scholar 

  • Bollinger, R.E.; Morris, J.H.; McKnight, F.G and Diederich, D.A.: Disappearance of 131I labelled insulin from plasma as a guide to management of diabetes. New England Journal of Medicine 270: 767–770 (1964).

    Google Scholar 

  • Bottermann, P.; Gyaram, H.; Wahl, K.; Ermler, R. and Lebender, A.: Pharmacokinetics of biosynthetic human insulin and characteristics of its effect. Diabetes 4: 168–169 (1981).

    CAS  Google Scholar 

  • Bruni, B.; Bruni, K.B.; Gamba, S.; Giolitti, A.; Rittatore, R. and Turco, G.L.: Long-term clinical trial with porcine monocomponent Lente insulin (Monotard®). Panminerva Medica 19: 247–254 (1977).

    PubMed  CAS  Google Scholar 

  • Bruni, B.; Gamba, S.; Regis, G. and Turco, G.L.: Proinsulin and α-component antibodies in diabetics after long-term mono-component insulin treatment. Diabetologia 14: 165–169 (1978).

    PubMed  CAS  Google Scholar 

  • Chance, R.E.; Kroeff, E.P.; Hoffman, J.A. and Frank, B.H.: Chemical, physical and biologic properties of biosynthetic human insulin. Diabetes Care 4: 147–154 (1981).

    PubMed  CAS  Google Scholar 

  • Chance, R.E.; Root, M.A. and Galloway J.A.: The immunogenicity of insulin preparations. Acta Endocrinologica 83(Suppl. 205): 185–198 (1976).

    CAS  Google Scholar 

  • Christy, M.; Deckert, T. and Nerup, J.: Immunity and autoimmunity in diabetes mellitus. Clinics in Endocrinology and Metabolism 6: 305–332 (1977).

    PubMed  CAS  Google Scholar 

  • Crome, P. and Keen, H.: Partial lipodystrophy and insulin-resistant diabetes. Diabetes et Metabolisme 4: 81–84 (1978).

    CAS  Google Scholar 

  • Davidson, J.K. and De Bra, D.W.: Immunologic insulin resistance. Diabetes 27: 307–318 (1978).

    PubMed  CAS  Google Scholar 

  • Deckert, T.; Andersen, O.O.; Grundahl, E. and Kerp, L.: Isoimmunization of man by recrystallized human insulin. Diabetologica 8: 358–361 (1972).

    CAS  Google Scholar 

  • Deckert, T.; Andersen, O.O. and Poulsen, J.E.: The clinical significance of highly purified pig insulin preparations. Diabetologia 10: 703–708 (1974).

    PubMed  CAS  Google Scholar 

  • De Meyts, P.; Halban, P. and Hepp, K.D.: In vitro studies on biosynthetic human insulin: An overview. Diabetes Care 4: 144–146 (1981).

    PubMed  Google Scholar 

  • Dixon, K.; Exon, P.D. and Malins, J.M.: Insulin antibodies and the control of diabetes. Quarterly Journal of Medicine 176: 543–553 (1975).

    Google Scholar 

  • Dolovich, J.; Schnatz, J.D.; Reisman, R.E.; Yage, Y. and Arbesman, C.E.: Insulin allergy and insulin resistance. Journal of Allergy 46: 127–137 (1970).

    PubMed  CAS  Google Scholar 

  • Federlin, K.; Laube, H. and Velcovsky, H.G.: Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin. Diabetes Care 4: 170–174 (1981).

    PubMed  CAS  Google Scholar 

  • Foiling, I.: Insulin-anti-insulin complexes. Acta Endocrinologica 83(Suppl. 205): 199–209 (1976).

    Google Scholar 

  • Gale, E.A.M.; Kurtz, A.B. and Tattersall, R.B.: In search of the Somogyi effect. Lancet 2: 279–282 (1980).

    PubMed  CAS  Google Scholar 

  • Galloway, J.A.: Insulin treatment for the early 80s: facts and questions about old and new insulins and their usage. Diabetes Care 3: 615–622 (1980).

    PubMed  CAS  Google Scholar 

  • Galloway, J.A. and Bressler, R.: Insulin treatment in diabetics. Medical Clinic of North America 62: 663–680 (1978).

    CAS  Google Scholar 

  • Galloway, J.A.; Spradlin, C.T.; Root, M.A. and Fineberg, S.E.: The plasma glucose response of normal fasting subjects to neutral regular and NPH biosynthetic human and purified pork insulins. Diabetes Care 4: 183–188 (1981).

    PubMed  CAS  Google Scholar 

  • Gattner, H.G.; Donho, W. and Naithani, V.K.: Enzyme-catalysed semi-synthesis with insulin derivatives; in Brandenburg and Wollmer (Eds) Insulin Chemistry, Structure and Function of Insulin and Related Hormones. Proceedings of the Second International Insulin Symposium, Aachen, September 1979, pp.117–123 (Walter de Gryter, Berlin 1979).

    Google Scholar 

  • Gerlis, L.S.; Adeniyi-Jones, R.; Jones, R.H.; Barnes, G.D. and Sönksen, P.H.: Porcine and semi-synthetic human insulins: a comparison of their metabolism in man. Diabetologia 21: 274 (1981).

    Google Scholar 

  • Gill, G.V.; Home, P.D.; Massi-Benedetti, M.; Pernet, A.; Copaldo, B.; Husband, D.J.; Burrin, J.M.; Johnston, D.G. and Alberti, K.G.M.M.: Clinical and metabolic characteristics of patients with ‘brittle’ diabetes. Diabetologia 21: 507 (1981).

    Google Scholar 

  • Goeddel, D.V.; Kleid, D.G.; Bolivar, F.; Heyneker, H.L.; Yansura, D.G.; Crea, A.; Hirose, T.; Kraszewsli, A.; Itakura, K. and Riggs, A.D.: Expression in E. coli of chemically synthesized genes for human insulin. Proceedings of the National Academy of Sciences (USA) 76: 106–110 (1979).

    CAS  Google Scholar 

  • Goldman, J.; Baldwin, D.; Rubenstein, A.H.; Klink, D.D.; Blackard, W.G.; Fisher, L.K.; Roe, T.F. and Schnure, J.J.: Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. Journal of Clinical Investigation 63: 1050–1059 (1979).

    PubMed  CAS  Google Scholar 

  • Goldstein, H.H.: Allergy and diabetes; in Marble et al. (Eds.) Joslin’s Diabetes Mellitus, pp.701–707 (Lea and Febiger, Philadelphia 1971).

    Google Scholar 

  • Hagedorn, H.C.; Jensen, B.N.; Krarup, N.B. and Wodstrup, I.: Protamine insulinate. Journal of the American Medical Association 106: 177–180 (1936).

    CAS  Google Scholar 

  • Hallas-Møller, K.; Jersild, M.; Peterson, K. and Schlichtkrull, J.: Zinc insulin preparations for single daily injection. Journal of the American Medical Association 150: 1667–1671 (1952).

    Google Scholar 

  • Harfenist, E.J. and Craig, L.C.: Counter current distribution studies with insulin. Journal of the American Chemical Society 74: 3083–3087 (1952).

    CAS  Google Scholar 

  • Heding, L.G.; Persson, B. and Strongenberg, M.: B-cell function in newborn infants of diabetic mothers. Diabetologia 19: 427–432 (1980).

    PubMed  CAS  Google Scholar 

  • Home, P.D. and Alberti, K.G.M.M.: Human Insulin. Clinics in Endocrinology and Metabolism 11: 453–483 (1982).

    PubMed  CAS  Google Scholar 

  • Home, P.D.; Pickup, J.C.; Keen, H.; Alberti, K.G.M.M.; Parsons, J.A. and Binder, C.: Continuous subcutaneous insulin infusion: comparison of plasma insulin profiles after infusion or bolus injection of the mealtime dose. Metabolism 30: 439–442 (1981).

    PubMed  CAS  Google Scholar 

  • Home, P.D.; Massi-Benedetti, M.; Shepherd, G.A.A.; Hanning, I.; Alberti, K.G.M.M. and Owens, D.R.: A comparison of the activity and disposal of semi-synthetic human insulin and porcine insulin in normal man by the glucose clamp technique. Diabetologia 22: 41–45 (1982).

    PubMed  CAS  Google Scholar 

  • Irvine, W.J.; Al-Khateeb, S.F.; DiMario, U.; Feek, C.M.; Gray, R.S.; Edmond, B. and Duncan, C.J.: Soluble immune complexes in the sera of newly diagnosed insulin dependent diabetics and in treated diabetics. Clinical and Experimental Immunology 30: 16–21 (1977).

    PubMed  CAS  Google Scholar 

  • Irvine, W.J.; DiMario, U.; Feek, C.M.; Ting, A.; Morris, P.J.; Gray, R.S. and Duncan, L.J.P.: Insulin antibodies in relation to islet cell antibodies and HLA antigens in insulin-dependent (Type I) diabetes. Journal of Laboratory and Clinical Immunology 1: 111 (1978).

    Google Scholar 

  • Jones, G.R.; Statham, B.; Owens, D.R.; Jones, M.K. and Hayes, T.M.: Lipoatrophy and monocomponent porcine insulin. British Medical Journal 282: 190 (1981).

    PubMed  CAS  Google Scholar 

  • Jorpes, J.E.: Recrystallized insulin for diabetic patients with insulin allergy. Archives of Internal Medicine 83: 363–371 (1949).

    PubMed  CAS  Google Scholar 

  • Keen, H.; Glynne, A.; Pickup, J.C.; Viberti, G.C.; Bilous, R.W.; Jarrett, R.J. and Marsden, R.: Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy man. Lancet 2: 398–401 (1980).

    PubMed  CAS  Google Scholar 

  • Kodama, S.; Kasuga, M.; Seki, A.; Ninomiya, M.; Sakwrai, T.; Mosishita, Y.; Matsuo, M. and Matsuo, T.: Congenital generalized lipodystrophy with insulin-resistant diabetes. European Journal of Paediatrics 127: 111–119 (1978).

    CAS  Google Scholar 

  • Koenig, R.J.; Peterson, C.M.; Jones, R.L.; Saudek, C.; Lehrman, M. and Cerami, A.: Correlation of glucose regulation and haemoglobin A1c in diabetes mellitus. New England Journal of Medicine 295: 417–420 (1976).

    PubMed  CAS  Google Scholar 

  • Korp, W. and Levett, R.E.: Erfahrungen mit Monokomponenten-Insulin. Wiener Klinische Wochenschrift 85: 326–330 (1973).

    PubMed  CAS  Google Scholar 

  • Kumar, D.; Miller, L.V. and Mehtalia, S.D.: Use of dexamethasone in treatment of insulin lipoatrophy. Diabetes 26: 296–299 (1977).

    PubMed  CAS  Google Scholar 

  • Kurtz, A.B. and Nabarro, J.D.N.: Circulating insulin binding antibodies. Diabetologia 19: 329–334 (1980).

    PubMed  CAS  Google Scholar 

  • Kurtz, A.B.; Matthews, J.A.; Mustaffa, B.E.; Doggett, P.R. and Nabarro, J.D.N.: Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Diabetologia 18: 147–150 (1980).

    PubMed  CAS  Google Scholar 

  • Lavaux, J.P.; Ooms, H.A. and Christiansen, A.H.: Insulin antibodies in insulin-treated patients; a clinical trial with highly purified insulins. Excerpta Medica International Congress Series 316: 40–46 (1973).

    Google Scholar 

  • Leslie, D.: Generalised allergic reaction to monocomponent insulin. British Medical Journal 2: 736–737 (1977).

    PubMed  CAS  Google Scholar 

  • Lithner, F.: Treatment of diabetes mellitus with monocomponent insulins. A preliminary report. Opuscula Medica 20: 249–254 (1975).

    Google Scholar 

  • Logie, A.W. and Stowers, J.M.: Hazards of monocomponent insulin. British Medical Journal 1: 879–880 (1976).

    PubMed  CAS  Google Scholar 

  • Lougheed, W.D.; Woulfe-Flanagan, H.; Clement, J.R. and Albisser, A.M.: Insulin aggregation in artificial delivery systems. Diabetologia 19: 1–9 (1980).

    PubMed  CAS  Google Scholar 

  • Lowell, F.C.: Immunologic studies in insulin resistance: II. The presence of a neutralizing factor in the blood exhibiting some characteristics of an antibody. Journal of Clinical Investigation 23: 233–240 (1944).

    PubMed  CAS  Google Scholar 

  • Ludvigsson, J. and Heding, L.G.: C-peptide in children with juvenile diabetes. Diabetologia 12: 627–630 (1976).

    PubMed  CAS  Google Scholar 

  • Malherbe, C.; deGasparo, M.; de Hertogh, R. and Hoet, J.J.: Circadian variations of blood sugar and plasma insulin levels in man. Diabetologia 5: 397–404 (1969).

    PubMed  CAS  Google Scholar 

  • Märki, F. and Albrecht, W.: Biological activity of synthetic human insulin. Diabetologia 13: 293–295 (1977).

    PubMed  Google Scholar 

  • Markussen, J.; Jorgensen, K.; Thim, L.; Damgaard, U.; Sørensen, E.; Dodson, G. and Chawdhury, F.: Human monocomponent insulin: chemistry and characteristics of human insulin (Novo). Diabetologia 21: 302 (1981).

    Google Scholar 

  • Massi-Benedetti, M.; Burrin, J.M.; Capaldo, B. and Alberti, K.G.M.M.: A comparative study of the activity of biosynthetic human insulin and pork insulin using the glucose clamp technique in normal subjects. Diabetes Care 4: 163–167 (1981).

    PubMed  CAS  Google Scholar 

  • Miller, W.L. and Baxter, J.D.: Recombinant DNA — a new source of insulin. Diabetologia 18: 431–436 (1980).

    PubMed  CAS  Google Scholar 

  • Mirsky, I.A. and Kawamura, K.: Heterogeneity of crystalline insulin. Endocrinology 78: 1115–1119 (1966).

    PubMed  CAS  Google Scholar 

  • Morihara, K.; Oka, T. and Tsuzuki, H.: Semi-synthesis of human insulin by trypsin-catalysed replacement of Ala-B30 by Thr in porcine insulin. Nature 280: 412–413 (1979).

    PubMed  CAS  Google Scholar 

  • Mustaffa, B.E.; Daggett, P.R. and Nabarro, J.D.N.: Insulin binding capacity in patients changed from conventional to highly purified insulins. An indication of likely response. Diabetologia 13: 311–315 (1977).

    PubMed  CAS  Google Scholar 

  • Nakagawa, S.; Suda, N.; Kudo, M. and Kawasaki, M.: A new Type of hypoglycaemia in a newborn infant. Diabetologia 9: 367–375 (1973).

    PubMed  CAS  Google Scholar 

  • National Diabetes Advisory Board: A study of insulin supply and demand. US Department of Health, Education and Welfare (NIH), 78-1588 (1978).

    Google Scholar 

  • Nicol, D.S.H. and Smith, L.F.: Amino-acid sequence of human insulin. Nature 187: 483–485 (1960).

    PubMed  CAS  Google Scholar 

  • Oakley, N.W.: Effect of ‘fractional’ insulins on total plasma insulin binding capacity and insulin requirement in severe diabetes. Lancet 1: 994–996 (1976).

    PubMed  CAS  Google Scholar 

  • Owens, D.R.; Jones, M.K.; Hayes, T.M.; Heding, L.G.; Alberti, K.G.M.M.; Home, P.D.; Burrin, J.M. and Newcombe, R.G.: Human insulin: study of safety and efficacy in man. British Medical Journal 282: 1264–1266 (1981).

    PubMed  CAS  Google Scholar 

  • Phelps, R.L.; Freinkel, N.; Rubenstein, A.H.; Kuzuya, H.; Metzger, B.E.; Boehm, J.J. and Mølsted-Pedersen, L.: Carbohydrate metabolism in pregnancy. XV. Plasma C-peptide during intravenous glucose tolerance in neonates from normal and insulin-treated diabetic mothers. Journal of Clinical Endocrinology and Metabolism 46: 61–68 (1978).

    PubMed  CAS  Google Scholar 

  • Pickup, J.C.; Home, P.D.; Bilous, R.W.; Keen, H. and Alberti, K.G.M.M.: Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. British Medical Journal 282: 347–350 (1981).

    PubMed  CAS  Google Scholar 

  • Pickup, J.C. and Keen, H.: Continuous subcutaneous insulin infusion: a developing tool in diabetes research. Diabetologia 18: 1–4 (1980).

    PubMed  CAS  Google Scholar 

  • Pickup, J.C.; Keen, H.; Viberti, G.C.; White, M.C.; Kohner, E.M.; Parsons, J.A. and Alberti, K.G.M.M.: Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care 3: 290–300 (1980).

    PubMed  CAS  Google Scholar 

  • Pirro de, R.; Fusco, A.; Spallone, L.; Mignatta, R. and Lauro, R.: Insulin antibodies prevent insulin receptor interaction. Diabetologia 19: 118–122 (1981).

    Google Scholar 

  • Raptis, S.; Karaiskos, C.; Enzmann, F.; Hatzidakis, D.; Zoupas, C.; Souvatzoglou, A.; Diamantopoulos, E. and Moulopoulos, S.: Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas. Diabetes Care 4: 140–143 (1981).

    PubMed  Google Scholar 

  • Reeves, W.G.: Immunology of diabetes and insulin therapy; in Thompson (Ed.) Recent Advances in Clinical Immunology, No. 2, pp. 182–200 (Churchill Livingstone Inc., Edinburgh 1980).

    Google Scholar 

  • Reeves, W.G. and Dodson, G.G.: Binding specificity of human insulin antibodies. Diabetologia 21: 319 (1981).

    Google Scholar 

  • Reeves, W.G.; Allen, B.R. and Tattersall, R.B.: Insulin induced lipoatrophy: evidence for an immune pathogenesis. British Medical Journal 280: 1500–1503 (1980).

    PubMed  CAS  Google Scholar 

  • Root, M.A.; Chance, R.E. and Galloway, J.A.: Immunogenicity of insulin. Diabetes 21(Suppl. 2): 657–660 (1972).

    PubMed  CAS  Google Scholar 

  • Root, M.A.; Spradlin, C.T.; Galloway, J.A. and Chance, R.E.: Factors affecting the measurement of insulin in the blood of human subjects following the administration of purified pork and human insulin. Diabetologia 21: 321 (1981).

    Google Scholar 

  • Roy, B.; Chou, M.C.Y, and Field, J.B.: Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. Journal of Clinical Endocrinology and Metabolism 50: 475 (1980).

    PubMed  CAS  Google Scholar 

  • Schernthaner, G.; Borkenstein, M.; Mathä, R.; Mayr, W.R. and Schober, E.: Analysis of insulin antibodies following human or pork MC insulin therapy in HLA-DR Typed juvenile diabetics: a prospective study. Diabetologia 21: 324 (1981).

    Google Scholar 

  • Schlichtkrull, J.: Antigenicity of monocomponent insulins. Lancet 2: 1260–1261 (1974).

    PubMed  CAS  Google Scholar 

  • Schlichtkrull, J.; Bronge, J.; Ege, H.; Hallund, O.; Heding, L.G.; Jørgensen, K.; Markussen, J.; Stahnke, J.; Sundby, F. and Volund, A.: Proinsulin and related peptides. Diabetologia 6: 80–81 (1970).

    Google Scholar 

  • Scott, D.A. and Fisher, A.M.: Studies on insulin with protamine. Journal of Pharmacology and Experimental Therapeutics 58: 78–92 (1936).

    CAS  Google Scholar 

  • Sieber, P.; Kamber, B.; Holtmann, A.; Jöhl, A.; Riniker, B. and Rittel, W.: Total Synthese von Humaninsulin Gezielter Bildung der Disulfidbindungen. Helvetica Chimica Acta 57: 2617–2621 (1974).

    PubMed  CAS  Google Scholar 

  • Spellacy, W.N. and Goetz, F.C.: Insulin antibodies in pregnancy. Lancet 2: 222–224 (1963).

    PubMed  CAS  Google Scholar 

  • Starzynska, R.; Seniow, S.; Kodejszko, F.; Kowalski, H.; Starzynski, S. and Depowska, B.: Studies on the transport of insulin antibodies across the placenta to the fetus and their effect on the fetal pancreatic islet system. Acta Diabetologica Latina 6: 573–584 (1969).

    Google Scholar 

  • Staub, A.; Sinn, L. and Behrens, O.K.: Purification and crystallization of hyperglycemic-glycogenolytic factor (HGF). Science 117: 628–629 (1953).

    PubMed  CAS  Google Scholar 

  • Steiner, D.F.; Hallund, O.; Rubenstein, A.; Cho, S. and Bayliss, C.: Isolation and properties of proinsulin, intermediate forms, and other minor components from crystalline bovine insulin. Diabetes 17: 725–736 (1968).

    PubMed  CAS  Google Scholar 

  • Stout, R.W.: Diabetes and atherosclerosis — the role of insulin. Diabetologia 16: 141–150 (1979).

    PubMed  CAS  Google Scholar 

  • Taylor, R.; Home, P.D. and Alberti, K.G.M.M.: Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection. Diabetes Care 4: 377–379 (1981).

    PubMed  CAS  Google Scholar 

  • Teuscher, A.: The place of the ‘monocomponent’ insulins in the therapy of diabetes mellitus. Schweizerische Medizinische Wochenschrift 105: 485–494 (1975).

    PubMed  CAS  Google Scholar 

  • Teuscher, A.: Die biologische Wirkung von vollsynthetischem humanem Insulin bei Patienten mit Diabetes Mellitus. Schweizerische Medizinische Wochenschrift 109: 743–747 (1979).

    PubMed  CAS  Google Scholar 

  • Villa-Komaroff, L.; Efstratiodis, A.; Broome, S.; Lomedico, P.; Tizard, R.; Naber, S.P.; Chick, W.L. and Gilbert, W.: A bacterial clone synthesizing proinsulin. Proceedings of the National Academy of Sciences (USA) 75: 3727–3731 (1978).

    CAS  Google Scholar 

  • Villa-Komaroff, L.; Naber, S.P.; Broome, S.; Efstratiadis, A.; Lomedico, P.; Tizard, R.; Chick, W.L. and Gilbert, W.: Synthesis of proinsulin in bacteria; in Beers et al. (Eds) Polypeptide Hormones, pp.49–63 (Raven Press, New York 1980).

    Google Scholar 

  • Wehner, H.; Huber, H. and Kronenberg, K.H.: The glomerular basement membrane of the rabbit kidney on long-term treatment with heterologous insulin preparations of different purity. Diabetologia 4: 255–263 (1973).

    Google Scholar 

  • Winkle Van, M. and Levy, L.: Further studies on the reversibility of serum sickness cholesterol-induced atherosclerosis. Journal of Experimental Medicine 132: 858–867 (1970).

    PubMed  Google Scholar 

  • Witters, L.A.; Ohman, J.L.; Weir, G.C.; Raymond, L.W. and Lowell, F.C.: Insulin antibodies in the pathogenesis of insulin allergy and resistance. American Journal of Medicine 63: 703–709 (1977).

    PubMed  CAS  Google Scholar 

  • Wright, A.D.; Walsh, C.H.; Fitzgerald, M.G. and Malins, J.M.: Very pure porcine insulin in clinical practice. British Medical Journal 1: 25–27 (1979).

    PubMed  CAS  Google Scholar 

  • Yue, D.K. and Turtle, J.R.: Antigenicity of ‘monocomponent’ pork insulin in diabetic subjects. Diabetes 24: 625–632 (1975).

    PubMed  CAS  Google Scholar 

  • Yue, D.K. and Turtle, J.R.: New forms of insulin and their use in the treatment of diabetes. Diabetes 26: 341–345 (1977).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Biochemistry and Metabolic Medicine, The Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, England

    P. D. Home &  K. G. M. M. Alberti

Authors
  1. P. D. Home
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. G. M. M. Alberti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Home, P.D., Alberti, K.G.M.M. The New Insulins. Drugs 24, 401–413 (1982). https://doi.org/10.2165/00003495-198224050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198224050-00003

Keywords

Search

Navigation